Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Van Buchem disease decoded

17.06.2005


Study underscores the importance of non-coding DNA in disease determination



Today a team of scientists provides convincing evidence that the deletion of a large non-coding DNA segment on human chromosome 17 is responsible for Van Buchem disease. This genetic mutation is one of only a few disease-associated mutations discovered to date that alters a long-range transcriptional regulatory element. The study appears online in the journal Genome Research.

"Our study addresses a fundamental issue with regards to the majority of the human genome that is non-coding in nature, and its potential impact on human health," explains Dr. Gabriela Loots, a scientist in the Department of Genome Biology at Lawrence Livermore National Laboratory who headed the study. "Non-coding regions located far away from the genes they regulate are critical for normal gene expression and are capable of leading to dramatic abnormal phenotypes if altered or deleted."


Van Buchem disease is a rare hereditary disorder of the skeletal system that is characterized by progressive osteosclerosis, particularly in the skull and mandible, but also in the clavicles, ribs, and diaphyses of long bones. Consequences of this increased bone mass usually include facial distortions and pinching of cranial nerves, and the increased nerve pressure often leads to deafness and blindness. Onset of the disease generally occurs during childhood and is manifested only in individuals carrying two copies of the mutant allele.

The locus responsible for Van Buchem disease was previously mapped to the short arm of human chromosome 17 near the gene sclerostin (or SOST), whose protein product functions as a negative regulator of bone formation. Mutations in the protein-coding regions of SOST are known to be responsible for sclerosteosis, another genetic disorder with attributes similar to Van Buchem disease. Because SOST was therefore a strong causal candidate for Van Buchem disease, scientists screened the SOST coding sequence for associated mutations, but to no avail.

Recently, however, a large 52-kilobase deletion was identified at a significant distance – approximately 35 kilobases – from the SOST gene in humans. This deletion, although associated perfectly with Van Buchem disease, removed a large non-protein-coding region; thus, its function, if any, in the development of the disease remained unclear.

The current study, which was led by Dr. Loots, was designed to rigorously investigate the underlying molecular mechanism by which this non-coding sequence might ultimately give rise to Van Buchem disease. Her team included researchers from Lawrence Berkeley National Laboratory (Berkeley, CA), the Novartis Institutes for BioMedical Research (Basel, Switzerland), and the DOE Joint Genome Institute (Walnut Creek, CA).

Dr. Loots and her colleagues engineered a human bacterial artificial chromosome (BAC) and generated transgenic mice with and without the 52 kilobases of DNA that are absent in Van Buchem patients. Although SOST was expressed normally in the early mouse embryo from both lines, SOST was dramatically downregulated in adult mice carrying the deletion, when compared to wild-type transgenic mice. These results provided strong evidence that the lack of SOST expression in humans homozygous for the 52-kilobase deletion is caused by a regulatory element – most likely an enhancer – that is located within the 52-kilobase region and that functions in a bone- and age-specific manner.

The team then utilized comparative sequence analyses and transient transfection assays to identify the actual enhancer sequence within the 52-kilobase deletion region that is responsible for SOST regulation. They aligned 140-kilobases of the human SOST region with the orthologous mouse sequence and identified seven evolutionarily conserved regions (ECRs). The seven ECRs were subjected to in vitro transient transfection enhancer analyses, and one of them – a 250-base-pair region named ECR5 – was found to drive expression in osteoblast-like cells.

These results provide a strong causal link between the 52-kilobase deletion and Van Buchem disease in humans. Drs. Michaela Kneissel and Hansjoerg Keller, collaborators on the project from the Novartis Institutes for BioMedical Research in Basel, Switzerland, point out that, in addition to addressing a fundamental problem in genomics, this project has clinical relevance. "Human genetic diseases of the skeleton, such as sclerosteosis and Van Buchem disease, provide a starting point for understanding the modulation of anabolic bone formation, and ultimately have the potential to identify key molecular components that can be used as new therapeutic agents to treat individuals suffering from bone loss disorders," say the researchers.

On an important scientific note, the methodological approaches employed by these researchers in elucidating the basis for Van Buchem disease will be widely applicable and very powerful in the characterization of other distant, cis-acting regulatory elements.

Maria A. Smit | EurekAlert!
Further information:
http://www.cshl.edu

More articles from Life Sciences:

nachricht Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH

nachricht Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>